Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-26

FDA Approved: METHOCARBAMOL — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved an original application for a generic methocarbamol product from Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOCARBAMOL (Methocarbamol)

Snippet

ORIG AP for METHOCARBAMOL (METHOCARBAMOL)